γ-Cyclodextrin enhances the biopharmaceutical performance of Boswellia serrata extract: comparative in vitro and ex vivo evaluation

Poor oral bioavailability of boswellic acids (BAs) restricts the therapeutic potential of Boswellia serrata extracts (BSE), primarily due to low solubility and limited intestinal absorption. This study systematically evaluated cyclodextrin (CD)-based BSE formulations to identify a composition with the potential to enhance the biopharmaceutical performance of BAs. Native and substituted CDs were screened for BA solubilization. Selected BSE formulations were prepared by lyophilization and physical mixing and characterized using HPLC, FT-IR, PXRD and DSC. Dissolution was evaluated in fasted- and fed-state biorelevant media, followed by intestinal parallel artificial membrane permeability assay (PAMPA) and ex vivo porcine intestinal permeation studies. The greatest solubility enhancements were provided by γ-CDs. Lyophilizates markedly enhanced BA dissolution, with approximately 8–10-fold higher release in fasted-state medium and complete release in fed-state medium. In PAMPA, HP-γ-CD increased apparent BA permeability by up to 3–5-fold in fasted-state medium, versus 1.7–2.8-fold for native γ-CD. Conversely, ex vivo studies identified native γ-CD as the superior carrier, increasing cumulative BA permeation approximately 15-fold. The superior performance of γ-CDs is consistent with the hypothesis that their larger cavity provides favorable accommodation of bulky BAs. The contrasting PAMPA and ex vivo outcomes indicate that biopharmaceutical performance depends on the balance between solubilization, free-drug availability and membrane interactions rather than solubilization capacity alone. Native γ-CD demonstrated the most favorable overall performance, particularly in the ex vivo permeation model, supporting further evaluation of its potential to improve intestinal absorption of BAs.

Authors

Publication Details

Journal
Figshare
Published
2026-11-18
DOI
https://doi.org/10.6084/m9.figshare.35050076
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

γ-Cyclodextrin enhances the biopharmaceutical performance of Boswellia serrata extract: comparative in vitro and ex vivo evaluation

Réka Angi, Attila Hunyadi, György Tibor Balogh, Vivien Bárdos et al.
Figshare
Drug Solubulity and Delivery Systems
article

γ-Cyclodextrin enhances the biopharmaceutical performance of Boswellia serrata extract: comparative in vitro and ex vivo evaluation

Réka Angi, Attila Hunyadi, György Tibor Balogh, Vivien Bárdos, Bence Sipos, István Antal, Péter Püski, Nikolett Kállai‐Szabó, Fang‐Rong Chang, Levente Szőcs, Gábor Katona, Judit Hohmann, Marcell Stifter-Mursits, Dávid Hamar, Barbara Ádám
article en

Abstract

Poor oral bioavailability of boswellic acids (BAs) restricts the therapeutic potential of Boswellia serrata extracts (BSE), primarily due to low solubility and limited intestinal absorption. This study systematically evaluated cyclodextrin (CD)-based BSE formulations to identify a composition with the potential to enhance the biopharmaceutical performance of BAs. Native and substituted CDs were screened for BA solubilization. Selected BSE formulations were prepared by lyophilization and physical mixing and characterized using HPLC, FT-IR, PXRD and DSC. Dissolution was evaluated in fasted- and fed-state biorelevant media, followed by intestinal parallel artificial membrane permeability assay (PAMPA) and ex vivo porcine intestinal permeation studies. The greatest solubility enhancements were provided by γ-CDs. Lyophilizates markedly enhanced BA dissolution, with approximately 8–10-fold higher release in fasted-state medium and complete release in fed-state medium. In PAMPA, HP-γ-CD increased apparent BA permeability by up to 3–5-fold in fasted-state medium, versus 1.7–2.8-fold for native γ-CD. Conversely, ex vivo studies identified native γ-CD as the superior carrier, increasing cumulative BA permeation approximately 15-fold. The superior performance of γ-CDs is consistent with the hypothesis that their larger cavity provides favorable accommodation of bulky BAs. The contrasting PAMPA and ex vivo outcomes indicate that biopharmaceutical performance depends on the balance between solubilization, free-drug availability and membrane interactions rather than solubilization capacity alone. Native γ-CD demonstrated the most favorable overall performance, particularly in the ex vivo permeation model, supporting further evaluation of its potential to improve intestinal absorption of BAs.

Figshare
Good health and well-being
Drug Solubulity and Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon